Jagsonpal acquires 85% stake in Aequitas Healthcare for Rs 20.8 cr

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.2%1-day move

₹230.11

prior close

₹243.69

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+2.6+6.0+6.7+6.6+3.2+2.1+3.3+3.4+3.9+0.7-3.5———

Up moveDown movePending

AI summary

Jagsonpal Pharmaceuticals will acquire an 85% equity stake in Aequitas Healthcare, a Mumbai-based pharma company focused on selling and distributing products to hospitals, for Rs 20.8 crores. Aequitas reported Rs 53 crores revenue in FY26 and serves leading hospital chains across India. The deal is funded through internal accruals with no debt. Existing directors of Aequitas will retain the remaining 15%. The transaction is expected to close by 15 July 2026, marking Jagsonpal's strategic entry into the hospital segment.

Likely market impact

Diversifies into hospital channel sales; funded internally so no dilution or debt. Positive if Aequitas grows under new ownership.